Navigation Links
LA BioMed researcher honored for excellence in education
Date:6/9/2009

LOS ANGELES (June 9, 2009) Carl D. Stevens, MD, MPH, a researcher at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), recently received the Award for Excellence in Education from UCLA.

The David Geffen School of Medicine at the University of California, Los Angeles (UCLA) established the honor to "recognize outstanding dedication, innovation and sustained excellence in education."

Dr. Stevens is a clinical professor of medicine, director of curriculum development and director of combined degree programs at the David Geffen School of Medicine at UCLA. He serves as director of Quality and Process Improvement and as an attending physician in the Department of Emergency Medicine at Harbor-UCLA Medical Center.

"Congratulations to Dr. Stevens on this well-deserved honor for his many contributions to education," said LA BioMed President and CEO Carole Wagner Vallianos, Esq. "He has been a leader in the field, and he serves as an outstanding example of the high caliber of researchers and faculty at LA BioMed. We are proud of his many accomplishments."


'/>"/>

Contact: Laura Mecoy
LMecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert  

Page: 1

Related medicine news :

1. Entest BioMedical Inc. Adds Former National Cancer Institute Researcher to Scientific Advisory Board With Focus on Stem Cell Cancer Patient Therapies
2. LA BioMed researcher receives clinical teaching award
3. New Video Series Spotlights Role of Biomedical Engineers in Caring for Total Artificial Heart Patients
4. Response Biomedical Closes $12.65 million Unit Offering
5. LA BioMed Vice President named champion of immunization
6. Garth Fisher, M.D., F.A.C.S., World Renowned Plastic Surgeon and Co-Founder Of CellCeuticals(R) Biomedical Skin Treatments Revealed On E!s Keeping Up With The Kardashians as the Surgeon Behind Bruce Jenners New Face
7. Alpine Biomed Corporation to Integrate Bravo pH Monitoring With GastroTrac Software to Enhance Gastrodiagnostic Testing Capabilities
8. BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock
9. BioMed Realty Trust Announces Public Offering of 14,000,000 Shares of Common Stock
10. Response Biomedical Announces Proposed Unit Offering
11. BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
LA BioMed researcher honored for excellence in education
LA BioMed researcher honored for excellence in education
(Date:11/25/2009).../PRNewswire-USNewswire/--TheBlackAIDSInstituterece...veleadershipfor2010. ,, ThenewBoardMembersareah...olicy,law,finance,governmenthealthprograms,editori...omawiderangeofpersonalbackgroundsincludingbothhete...emselves,andrepresentingmultipleagegroups. ,, (...
(Date:11/25/2009)...dorsements,Business,andPressJoinEfforttoEducate ,...Onceagain,theNationalBipolarFoundationandtheMedicA...afe,tilStable"program,whichisnowbeingwidelyaccepte...Today,theNationalBipolarFoundationreceivedaproclam...mtheLt.GovernorofLouisianaMitchLandrieu.TheNationa...
(Date:11/25/2009)...evidence of a statistically significant survival b...e estrogen receptor (ER)-positive tumors had high ...18 (ER-alpha S118-P), according to a brief communi...l of the National Cancer Institute . , Approxima...oxifen. Preclinical studies have shown that ER-alp...
(Date:11/25/2009)...ood pressure? This simple question has been the f...ss-related gene Modulates High Blood Pressure in M...This simple question has been the focus of intense...r the first time established a link between a nove... to stress in mice as well as humans. The studies ...
(Date:11/25/2009)...o fight rheumatoid arthritis, could help newly dia...DAY, Nov. 25 (HealthDay News) -- A drug commonly u... arthritis now also shows some promise in helping ..., The drug, rituximab (Rituxan), helped patients k...gh the disease had destroyed some of their pancrea...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...re Holdings,Inc. (Amex: PRZ ), one of the nation,...rgical solutions and services, today announced tha...PSHS Alpha Partners, Ltd., which,owns and operates...es have provided for the release of approximately ...
...ce Patient Safety, Improve Efficiency, SAN RAMON,...lobal services firm that specializes in enabling,t...tions, today announced,that it has been awarded a ... install clinical components of its Keane,InSight ...
...idan and Others Join Carlos Santana to ...BOCA RATON, Fla., Sept. 5 Spirit of Women Health,...unce today the opening of,bidding for the Spirit o...ing the National Stroke Association and,Peripheral...
...nvulsants, Especially When Prescribed,Off-Label, ... effective in treating bipolar disorder, fibromyal...scribed drugs are not always the best,initial choi...lic information project of Consumers Union., The ...
...tech,Incorporated (Nasdaq: MTEX ), a leading deve... care solutions, today announced a new sales tools...nt sales force of more,than 569,000 independent As... the company,s largest annual gatherings of,sales ...
...ders to Bicycle a Combined 3,000 Miles in Two Wee...Health and Hope, PHILADELPHIA, Sept. 5 It,s poss...rage, live less healthy and possibly,even shorter ...aths and affect the quality of life of more than 9...
Other Medicine News:Health News:PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers 2Health News:PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers 3Health News:PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers 4Health News:Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility 2Health News:Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility 3Health News:Online Celebrity Shoe Charity Auction for Women's Heart Health Opens Bidding 2Health News:Online Celebrity Shoe Charity Auction for Women's Heart Health Opens Bidding 3Health News:Consumer Reports' Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best 2Health News:Consumer Reports' Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best 3Health News:Mannatech Launches Phase One of New Sales and Training Tools 2Health News:Mannatech Launches Phase One of New Sales and Training Tools 3Health News:CIGNA Employees Take to the Road to Promote Health and Wellness 2Health News:CIGNA Employees Take to the Road to Promote Health and Wellness 3Health News:CIGNA Employees Take to the Road to Promote Health and Wellness 4
(Date:11/25/2009)...if.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announ...sPROTECT-1(theProspectiveRandomizedOralTherapyEval...82-B)inpatientswithmoderate-to-severeCrohn,sdiseas...ndtolerabilityprofile.Thestudydemonstratedevidence...sdefinedasa70-pointdecreaseintheCrohn,sDiseaseActi...
(Date:11/24/2009)...4/PRNewswire/-- ,, WHAT:RomHoubens,aBelgianmant...ident,wasactuallyfullyconsciousandawakeduringthatt...eDynaVoxEyeMaxwasfeaturedinthesegmenttoillustrateh...unlockcommunication. ,, WHEN:GoodMorningAmerica...avoxtech.com ,, WHO:RomHoubenswasanengineer...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--QuestDiagnosticsIncorpo...ostictesting,informationandservices,announcedthati...thcareConferenceinNewYorkCity.Thepresentationissch...Time. ,, Duringtheconference,thecompanywillreaf...,operatingincometoexceed18%ofrevenues,anddilutedea...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Stereotactic Radiosurgery As Effective in Eliminating Parkinsons Disease Tremors As Other Treatments But Less Invasive 60570 1Stereotactic Radiosurgery As Effective in Eliminating Parkinsons Disease Tremors As Other Treatments But Less Invasive 60570 2Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and 26quot 3BArthritis Kits 26quot 3B 5937 1Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and 26quot 3BArthritis Kits 26quot 3B 5937 2Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and 26quot 3BArthritis Kits 26quot 3B 5937 3STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 1STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 2STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 3STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 4STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 5STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 6STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 7STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 8STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 9STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 10STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 11STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 12STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 13STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 14STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 15STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 16STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 17STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 18STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 19STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 20STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 21STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 22STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 23STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 24
...ented at ASCO Annual Meeting -, SOUTH SAN FRANCIS...ll/,-- Poniard Pharmaceuticals, Inc. (Nasdaq: PAR...gy, today announced safety and efficacy results,fr... of picoplatin and,liposomal doxorubicin in patien...ancer. Results demonstrated signals of clinical ac...
...cal Phase 2 data presented at American Society of ...eting, PRINCETON, N.J., June 1 Medarex, Inc.,(Na...llow-up and overall,survival (OS) results from a P...ilimumab in combination with dacarbazine (DTIC) wh...t or greater than 4 years of follow-up. This,inclu...
Other Medicine Technology:Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 2Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 3Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 4Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 5Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 2Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 3Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 4
SAS Strep A Test
Poly stat Strep A
HemataSTAT
CoaguChek S
Medicine Products: